Jan A. Bruijn

16.1k total citations · 3 hit papers
159 papers, 8.6k citations indexed

About

Jan A. Bruijn is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jan A. Bruijn has authored 159 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Nephrology, 42 papers in Pulmonary and Respiratory Medicine and 36 papers in Surgery. Recurrent topics in Jan A. Bruijn's work include Renal Diseases and Glomerulopathies (56 papers), Vasculitis and related conditions (32 papers) and Chronic Kidney Disease and Diabetes (23 papers). Jan A. Bruijn is often cited by papers focused on Renal Diseases and Glomerulopathies (56 papers), Vasculitis and related conditions (32 papers) and Chronic Kidney Disease and Diabetes (23 papers). Jan A. Bruijn collaborates with scholars based in Netherlands, United States and United Kingdom. Jan A. Bruijn's co-authors include Ingeborg M. Bajema, Emile de Heer, Franco Ferrario, Hans J. Baelde, E. Christiaan Hagen, Kensuke Joh, David Jayne, Michael Eikmans, Mark Haas and Rüdiger Waldherr and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Diabetes.

In The Last Decade

Jan A. Bruijn

158 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathologic Classification of Diabetic Nephropathy

2010 1.2k citations Cinthia B. Drachenberg, Franco Ferrario et al. Journal of the American Society of Nephrology profile →
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices

2018 595 citations Ingeborg M. Bajema, Jan A. Bruijn et al. Kidney International profile →
Histopathologic Classification of ANCA-Associated Glomerulonephritis

2010 580 citations Franco Ferrario, E. Christiaan Hagen et al. Journal of the American Society of Nephrology profile →

Peers

Countries citing papers authored by Jan A. Bruijn

Since Specialization

Citations

This map shows the geographic impact of Jan A. Bruijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan A. Bruijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan A. Bruijn more than expected).

Fields of papers citing papers by Jan A. Bruijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan A. Bruijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan A. Bruijn. The network helps show where Jan A. Bruijn may publish in the future.

Co-authorship network of co-authors of Jan A. Bruijn

This figure shows the co-authorship network connecting the top 25 collaborators of Jan A. Bruijn. A scholar is included among the top collaborators of Jan A. Bruijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan A. Bruijn. Jan A. Bruijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glomerular clusterin expression is increased in diabetic nephropathy and protects against oxidative stress-induced apoptosis in podocytes 2020 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Jan A. Bruijn, Marion Scharpfenecker, Hans J. Baelde	19
2	Glomerular permeability is not affected by heparan sulfate glycosaminoglycan deficiency in zebrafish embryos 2019 ·American Journal of Physiology-Renal Physiology ·Ramzi Khalil, Reshma A. Lalai, Małgorzata Wiweger, M. Cristina Avramut, Abraham J. Koster, Herman P. Spaink, Jan A. Bruijn, Pancras C.W. Hogendoorn, Hans J. Baelde	6
3	Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis 2019 ·Modern Pathology ·(unknown), Malu Zandbergen, Ron Wolterbeek, Hans J. Baelde, Leendert A. van Es, Johan W. de Fijter, Jan A. Bruijn, Ingeborg M. Bajema	43
4	Increased dynamin expression precedes proteinuria in glomerular disease 2018 ·The Journal of Pathology ·Ramzi Khalil, Klaas Koop, Reinhold Kreutz, Herman P. Spaink, Pancras C.W. Hogendoorn, Jan A. Bruijn, Hans J. Baelde	9
5	Macrophages in diabetic nephropathy in patients with type 2 diabetes 2016 ·Nephrology Dialysis Transplantation ·Céline Q.F. Klessens, Malu Zandbergen, Ron Wolterbeek, Jan A. Bruijn, Ton J. Rabelink, Ingeborg M. Bajema, Daphne H.T. IJpelaar	190
6	Diagnosis of Early Pancreas Graft Failure via Antibody-Mediated Rejection: Single-Center Experience With 256 Pancreas Transplantations 2014 ·American Journal of Transplantation ·Hanneke de Kort, Marko J.K. Mallat, Cees van Kooten, Emile de Heer, (unknown), A M van der Wal, Candice Roufosse, Dave L. Roelen, Jan A. Bruijn, Frans H.J. Claas, Johan W. de Fijter, Ingeborg M. Bajema	17
7	Pancreas Allograft Biopsies with Positive C4d Staining and Anti‐Donor Antibodies Related to Worse Outcome for Patients 2010 ·American Journal of Transplantation ·Hanneke de Kort, Raghava Munivenkatappa, Stefan P. Berger, Michael Eikmans, Annemieke van der Wal, Eelco J.P. de Koning, Cees van Kooten, Emile de Heer, Rolf N. Barth, Jan A. Bruijn, Benjamin Philosophe, Cinthia B. Drachenberg, Ingeborg M. Bajema	35
8	Hypotheses on the Etiology of Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis 2007 ·Clinical Journal of the American Society of Nephrology ·Robert A.F. de Lind van Wijngaarden, (unknown), E. Christiaan Hagen, Richard A. Watts, Gina Gregorini, Jan Willem Cohen Tervaert, Alfred Mahr, John L. Niles, Emile de Heer, Jan A. Bruijn, Ingeborg M. Bajema	69
9	Clinical and Histologic Determinants of Renal Outcome in ANCA-Associated Vasculitis 2006 ·Journal of the American Society of Nephrology ·Robert A.F. de Lind van Wijngaarden, Herbert A. Hauer, Ron Wolterbeek, David Jayne, Gill Gaskin, Niels Rasmussen, (unknown), Franco Ferrario, (unknown), E. Christiaan Hagen, Jan A. Bruijn, Ingeborg M. Bajema	191
10	The use of extracellular matrix probes and extracellular matrix-related probes for assessing diagnosis and prognosis in renal diseases 2004 ·Current Opinion in Nephrology & Hypertension ·Michael Eikmans, Daphne H.T. IJpelaar, Hans J. Baelde, Emile de Heer, Jan A. Bruijn	1
11	Calcium levels as a risk factor for delayed graft function 2004 ·Transplantation ·Henk Boom, Marko J.K. Mallat, Johan W. de Fijter, Lorna Paul, Jan A. Bruijn, Leendert A. van Es	48
12	Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy 2003 ·Kidney International ·René C. Bakker, A. A. M. J. Hollander, Marko J.K. Mallat, Jan A. Bruijn, Leendert C. Paul, Johan W. de Fijter	43
13	Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients 2002 ·Kidney International ·Herbert A. Hauer, Ingeborg M. Bajema, Hans C. van Houwelingen, Franco Ferrario, Laure‐Hélène Noël, Rüdiger Waldherr, David Jayne, Niels Rasmussen, Jan A. Bruijn, E. Christiaan Hagen	165
14	Fibronectin accumulation in glomerulosclerotic lesions: Self-assembly sites and the heparin II binding domain 2002 ·Kidney International ·(unknown), (unknown), Hans J. Baelde, Emile de Heer, Jan A. Bruijn	15
15	High transforming growth factor-?? and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection1 2002 ·Transplantation ·Michael Eikmans, Yvo W.J. Sijpkens, Hans J. Baelde, Emile de Heer, Lorna Paul, Jan A. Bruijn	47
16	Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies 2001 ·Kidney International ·Michael Eikmans, Hans J. Baelde, Emile de Heer, Jan A. Bruijn	28
17	Remodeling of the porcine pulmonary autograft wall in the aortic position 2000 ·Journal of Thoracic and Cardiovascular Surgery ·Paul H. Schoof, Adriana C. Gittenberger–de Groot, Emile de Heer, Jan A. Bruijn, Mark G. Hazekamp, Hans A. Huysmans	30
18	Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane 1998 ·Diabetologia ·J.W. van der Pijl, M. R. Daha, Jacob van den Born, Nicole A.M. Verhagen, H. H. P. J. Lemkes, Richard Bucala, Jo H. M. Berden, A. H. Zwinderman, Jan A. Bruijn, Leendert A. van Es, Fokko J. van der Woude	26
19	Tissue chimerism in human cryopreserved homograft valve explants demonstrated by in situ hybridization 1998 ·The Annals of Thoracic Surgery ·David R. Koolbergen, Mark G. Hazekamp, (unknown), (unknown), Cees J. Cornelisse, Hans A. Huysmans, Jan A. Bruijn	19
20	Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane 1994 ·Diabetologia ·J.T. Tamsma, Jacob van den Born, Jan A. Bruijn, Karel J.M. Assmann, Jan J. Weening, J. H. M. Berden, Jörgen Wieslander, E. Schrama, J. Hermans, J.H. Veerkamp, H. H. P. J. Lemkes, Fokko J. van der Woude	144

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact